Related Experiment Video

Updated: Jul 8, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

INASL Consensus on Management of HCC: Navigating an Evolving Field

Amit G Singal1, Anjana Pillai2, Neehar D Parikh3

  • 1Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

Journal of Clinical and Experimental Hepatology
|December 11, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

446

Related Experiment Videos

Last Updated: Jul 8, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

446

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

71
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
71
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92

Articles linked to this work by shared authors, journal, and citation graph.

Mortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021.

The American journal of medicine·2025

Increased MASH-associated liver cancer in younger demographics.

Hepatology communications·2025

Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.

Alimentary pharmacology & therapeutics·2025

Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2024

Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.

Clinical and molecular hepatology·2024

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2024

Management Strategies and Clinical Outcomes in Steroid-resistant Rejection after Liver Transplantation: A Systematic Review and Meta-analysis.

Journal of clinical and experimental hepatology·2026

Digital Pathology-Enabled Artificial Intelligence for Fibrosis Assessment in Metabolic Dysfunction-Associated Steatohepatitis: Needs, Current Progress, and Barriers.

Journal of clinical and experimental hepatology·2026

Breaking Barriers in Hepatocellular Carcinoma: Synergistic Potential of Stereotactic Body Radiotherapy Combined With Immunotherapy.

Journal of clinical and experimental hepatology·2026

Outcomes of Pediatric ABO-Incompatible Living Donor Liver Transplantation: A Retrospective Single-Centre Experience from India.

Journal of clinical and experimental hepatology·2026

Predicting Recompensation in Alcohol, HBV and HCV-associated Decompensated Cirrhosis.

Journal of clinical and experimental hepatology·2026

Nephropathy Following Portosystemic Shunt Surgery in Children With Extrahepatic Portal Venous Obstruction: An Unusual Complication.

Journal of clinical and experimental hepatology·2026

Operational enablers and barriers in hospital incident command: insights from a single-center table-top exercise at a tertiary care university hospital-a qualitative phenomenological study.

Frontiers in public health·2026

Different types of human-AI interaction and employees' knowledge territorial behavior: the role of organizational dehumanization and paradoxical leadership.

Frontiers in psychology·2026

Algorithmic performance appraisal intensity in hospitals: implications for professional autonomy and innovative work behavior.

Frontiers in psychology·2026

Integrated Physics-Informed Machine Learning Framework for Structural Damage Detection, Localization, and Severity Classification.

Sensors (Basel, Switzerland)·2026

Evaluating the Resilience of ICU Nurse Staffing Standard Operating Procedures Under Demand Variability: A Discrete Event Simulation Study Using MIMIC-IV.

Healthcare (Basel, Switzerland)·2026

Implementation of automated alerts for last-resort antibiotics with indication review by infectious diseases specialists: impact on antibiotic prescription quality and costs.

Infection·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us